Found: 22
Select item for more details and to access through your institution.
Discovery of a Highly Potent and Broadly Effective Epidermal Growth Factor Receptor and HER2 Exon 20 Insertion Mutant Inhibitor.
- Published in:
- Angewandte Chemie, 2018, v. 130, n. 36, p. 11803, doi. 10.1002/ange.201805187
- By:
- Publication type:
- Article
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 4, p. 452, doi. 10.1093/jjco/hyad195
- By:
- Publication type:
- Article
Discovery of a Highly Potent and Broadly Effective Epidermal Growth Factor Receptor and HER2 Exon 20 Insertion Mutant Inhibitor.
- Published in:
- Angewandte Chemie International Edition, 2018, v. 57, n. 36, p. 11629, doi. 10.1002/anie.201805187
- By:
- Publication type:
- Article
Hemophagocytic lymphohistiocytosis induced by nivolumab/ipilimumab combination therapy: A case of lung adenocarcinoma that responded to early steroid pulse therapy.
- Published in:
- Cancer Reports, 2024, v. 7, n. 2, p. 1, doi. 10.1002/cnr2.1960
- By:
- Publication type:
- Article
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 4, p. 529, doi. 10.1007/s10637-017-0453-0
- By:
- Publication type:
- Article
Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 3, p. 394, doi. 10.1007/s10637-016-0329-8
- By:
- Publication type:
- Article
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 9, p. 1628, doi. 10.1007/s10147-021-01947-3
- By:
- Publication type:
- Article
Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.
- Published in:
- Lung Cancer: Targets & Therapy, 2024, v. 15, p. 87, doi. 10.2147/LCTT.S463429
- By:
- Publication type:
- Article
Clinical implications of bronchoscopy for immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Targeting MET Amplification as a New Oncogenic Driver.
- Published in:
- Cancers, 2014, v. 6, n. 3, p. 1540, doi. 10.3390/cancers6031540
- By:
- Publication type:
- Article
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 3, p. 1258, doi. 10.1002/cam4.1995
- By:
- Publication type:
- Article
Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55939-5
- By:
- Publication type:
- Article
Regression of brain metastases from breast cancer with eribulin: a case report.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 11, p. 1783, doi. 10.1038/s41416-024-02662-2
- By:
- Publication type:
- Article
Marked response to both S-1 and pemetrexed in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinoma.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Phase I/II Study of Cisplatin plus Nab‐Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. 19, doi. 10.1002/ONCO.13524
- By:
- Publication type:
- Article
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.
- Published in:
- Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13941
- By:
- Publication type:
- Article
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L.
- Published in:
- Cancer Science, 2022, v. 113, n. 1, p. 221, doi. 10.1111/cas.15176
- By:
- Publication type:
- Article
Mutational activation of the epidermal growth factor receptor down‐regulates major histocompatibility complex class I expression via the extracellular signal‐regulated kinase in non–small cell lung cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 1, p. 52, doi. 10.1111/cas.13860
- By:
- Publication type:
- Article
FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
- Published in:
- Cancer Science, 2016, v. 107, n. 11, p. 1667, doi. 10.1111/cas.13071
- By:
- Publication type:
- Article
Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer.
- Published in:
- Cancer Science, 2015, v. 106, n. 6, p. 734, doi. 10.1111/cas.12658
- By:
- Publication type:
- Article
Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45337-3
- By:
- Publication type:
- Article